BIAF's 522,877-Share Float Faces 616,135 Pre-Funded Warrants Already Paid In Full

bioAffinity Technologies carries a dilution risk score of 8 out of 10, with total pending supply equal to 366% of its tradeable float and an unresolved filing contradiction on the single most dangerous term in its capital structure.